バイオベンチャー列伝2(週刊東洋経済eビジネス新書No.139)
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
£0.00 for first 30 days
Pick 1 audiobook a month from our unmatched collection - including bestsellers and new releases.
Listen all you want to thousands of included audiobooks, Originals, celeb exclusives, and podcasts.
Access exclusive sales and deals.
£7.99/month after 30 days. Renews automatically. See here for eligibility.
バイオベンチャー列伝2(週刊東洋経済eビジネス新書No.139)
Narrated by:
海老塚 久蔵
Buy Now for £5.99
No valid payment method on file.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By completing your purchase, you agree to Audible's Conditions of Use and authorise Audible to charge your designated card or any other card on file. Please see our Privacy Notice, Cookies Notice and Interest-based Ads Notice.
-
Narrated by:
-
海老塚 久蔵
-
By:
-
週刊東洋経済編集部
About this listen
米国で設立後に日本で上場、中国で創薬を行う異色ベンチャー・ジーエヌアイグループ、遺伝子治療薬の開発を行うアンジェス ＭＧ、がん治療薬を開発するナノキャリア……。
創薬系バイオベンチャー企業は高い成長が期待できる反面、新薬開発には長い?月と多額の研究費用を要するうえに、すべての開発が成功するとは限らず、リスクも高い。
はたして今回紹介する中から大化けする企業は出てくるのか!?
本書は、東洋経済新報社のサイト「会社四季報オンライン」に掲載された連載「大化け創薬ベンチャーを探せ！」を加筆修正のうえ制作しています。
©東洋経済新報社 (P)2019 Audible, Inc.
activate_Holiday_promo_in_buybox_DT_T2